Advertisement

Index by author

September 01, 1983; Volume 226,Issue 3

A

  1. Aarhus, L L

    1. Alpha-1 adrenoceptors and calcium in isolated canine coronary arteries.
      T J Rimele, T W Rooke, L L Aarhus and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 668-672;

  2. Accomando, R C

    1. Antihypertensive activity of dl-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl prostaglandin E2 methyl ester (CL 115,347), a new orally and transdermally long-acting antihypertensive agent.
      P S Chan, P Cervoni, M A Ronsberg, R C Accomando, G J Quirk, P A Scully and L M Lipchuck
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 726-732;

  3. Aderounmu, A F

    1. Pharmacokinetics of chloroquine diphosphate in the dog.
      A F Aderounmu and L Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 633-639;

  4. Akera, T

    1. Negative chronotropic and positive inotropic actions of phencyclidine on isolated atrial muscle in guinea pigs and rats.
      K Temma, T Akera, T M Brody and R H Rech
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 885-892;

  5. Ator, N A

    1. Lorazepam and pentobarbital drug discrimination in baboons: cross-drug generalization and interaction with Ro 15-1788.
      N A Ator and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 776-782;

B

  1. Barcas, P P

    1. Medullary gamma-aminobutyric acid (GABA) receptors and the regulation of blood pressure in the rat.
      R N Willette, A J Krieger, P P Barcas and H N Sapru
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 893-899;

  2. Barker, L A

    1. Evaluation of presynaptic histamine receptors in the canine renal vascular bed.
      N W Robie and L A Barker
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 712-719;

  3. Böke, T

    1. Enhancement by locally generated angiotensin II of release of the adrenergic transmitter in the isolated rat kidney.
      T Böke and K U Malik
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 900-907;

  4. Braughler, J M

    1. Pre- and postnatal effects of caffeine on brain biogenic amines, cyclic nucleotides and behavior in developing rats.
      J T Concannon, J M Braughler and M D Schechter
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 673-679;

  5. Breese, G R

    1. Differential sensitivity of ethanol withdrawal signs in the rat to gamma-aminobutyric acid (GABA)mimetics: blockade of audiogenic seizures but not forelimb tremors.
      G D Frye, T J McCown and G R Breese
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 720-725;

  6. Brody, T M

    1. Negative chronotropic and positive inotropic actions of phencyclidine on isolated atrial muscle in guinea pigs and rats.
      K Temma, T Akera, T M Brody and R H Rech
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 885-892;

  7. Browne, R G

    1. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
      B K Koe, A Weissman, W M Welch and R G Browne
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 686-700;

  8. Browning, M C

    1. Reactivity and binding of beta-lactam antibiotics in rabbit renal cortex.
      M C Browning and B M Tune
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 640-644;

  9. Burch, J B

    1. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors.
      M J Marks, J B Burch and A C Collins
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 817-825;

  10. Burch, R M

    1. Verapamil inhibition of vasopressin-stimulated water flow: possible role of intracellular calcium.
      R M Burch and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 701-705;

C

  1. Cervoni, P

    1. Antihypertensive activity of dl-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl prostaglandin E2 methyl ester (CL 115,347), a new orally and transdermally long-acting antihypertensive agent.
      P S Chan, P Cervoni, M A Ronsberg, R C Accomando, G J Quirk, P A Scully and L M Lipchuck
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 726-732;

  2. Chan, P S

    1. Antihypertensive activity of dl-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl prostaglandin E2 methyl ester (CL 115,347), a new orally and transdermally long-acting antihypertensive agent.
      P S Chan, P Cervoni, M A Ronsberg, R C Accomando, G J Quirk, P A Scully and L M Lipchuck
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 726-732;

  3. Chen, T S

    1. Transport of methotrexate in cortical slices of monkey kidney: effect of organic anions and vincristine.
      T S Chen, B A Wenczak and K C Huang
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 645-649;

  4. Cherian, S

    1. Physical dependence on diazepam and lorazepam in the dog.
      L F McNicholas, W R Martin and S Cherian
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 783-789;

  5. Cho, A K

    1. Xylamine, an irreversible inhibitor of norepinephrine uptake, is transported by this same uptake mechanism in cultured rat superior cervical ganglia.
      J B Fischer, L A Waggaman, R W Ransom and A K Cho
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 650-655;

  6. Cicero, T J

    1. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
      T J Cicero, D P Owens, P F Schmoeker and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 770-775;

  7. Collins, A C

    1. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors.
      M J Marks, J B Burch and A C Collins
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 817-825;

  8. Concannon, J T

    1. Pre- and postnatal effects of caffeine on brain biogenic amines, cyclic nucleotides and behavior in developing rats.
      J T Concannon, J M Braughler and M D Schechter
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 673-679;

  9. Cooper, J K

    1. A study of the kinetics of chlorpromazine sulfoxide by a specific radioimmunoassay after a single oral dose of chlorpromazine in healthy volunteers.
      P K Yeung, J W Hubbard, J K Cooper and K K Midha
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 833-838;

  10. Corradetti, R

    1. Mobilization of cellular choline by stimulation of muscarine receptors in isolated chicken heart and rat cortex in vivo.
      R Corradetti, R Lindmar and K Löffelholz
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 826-832;

  11. Cubeddu, L X

    1. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
      L X Cubeddu, I S Hoffmann, M K James and D M Niedzwiecki
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 680-685;

D

  1. Davidesko, D

    1. Differential role of M-1 and M-2 receptors in sympathetic ganglia of the pithed normotensive rat in alpha adrenoceptor-mediated vasoconstriction.
      B Wilffert, D Davidesko, P B Timmermans and P A van Zwieten
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 855-860;

  2. de Paul Lynch, V

    1. Effect of chronic lithium treatment on rat pineal rhythms: N-acetyltransferase, N-acetylserotonin and melatonin.
      F D Yocca, V de Paul Lynch and E Friedman
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 733-737;

F

  1. Fischer, J B

    1. Xylamine, an irreversible inhibitor of norepinephrine uptake, is transported by this same uptake mechanism in cultured rat superior cervical ganglia.
      J B Fischer, L A Waggaman, R W Ransom and A K Cho
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 650-655;

  2. Fleckenstein, L

    1. Pharmacokinetics of chloroquine diphosphate in the dog.
      A F Aderounmu and L Fleckenstein
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 633-639;

  3. Frey, H H

    1. High anticonvulsant potency of gamma-aminobutyric acid (GABA)mimetic drugs in gerbils with genetically determined epilepsy.
      W Löscher, H H Frey, R Reiche and D Schultz
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 839-844;

  4. Friedman, E

    1. Effect of chronic lithium treatment on rat pineal rhythms: N-acetyltransferase, N-acetylserotonin and melatonin.
      F D Yocca, V de Paul Lynch and E Friedman
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 733-737;

  5. Frye, G D

    1. Differential sensitivity of ethanol withdrawal signs in the rat to gamma-aminobutyric acid (GABA)mimetics: blockade of audiogenic seizures but not forelimb tremors.
      G D Frye, T J McCown and G R Breese
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 720-725;

G

  1. Gallagher, J P

    1. Effects of glial uptake and desensitization on the activity of gamma-aminobutyric acid (GABA) and its analogs at the cat dorsal root ganglion.
      J P Gallagher, J Nakamura and P Shinnick-Gallagher
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 876-884;

  2. Galloway, M P

    1. Noradrenergic modulation of serotonin synthesis and metabolism. II. Stimulation by 3-isobutyl-1-methylxanthine.
      J F Reinhard, M P Galloway and R H Roth
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 764-769;

  3. Garzón, J

    1. Functional opiate receptor in mouse vas deferens: evidence for a complex interaction.
      P Sánchez-Blázquez, J Garzón and N M Lee
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 706-711;

  4. Glaumann, H

    1. Styrene oxide metabolism in rhesus monkey liver: enzyme activities in subcellular fractions and in isolated hepatocytes.
      G M Pacifici, B Lindberg, H Glaumann and A Rane
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 869-875;

  5. Gram, T E

    1. Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers.
      E G Mimnaugh, T E Gram and M A Trush
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 806-816;

  6. Griffiths, R R

    1. Lorazepam and pentobarbital drug discrimination in baboons: cross-drug generalization and interaction with Ro 15-1788.
      N A Ator and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 776-782;

H

  1. Halushka, P V

    1. Verapamil inhibition of vasopressin-stimulated water flow: possible role of intracellular calcium.
      R M Burch and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 701-705;

  2. Hoffmann, I S

    1. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
      L X Cubeddu, I S Hoffmann, M K James and D M Niedzwiecki
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 680-685;

  3. Hojvat, S A

    1. Stimulation of prostaglandin production in rabbit ileal mucosa by bradykinin.
      S A Hojvat, M W Musch and R J Miller
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 749-755;

  4. Huang, K C

    1. Transport of methotrexate in cortical slices of monkey kidney: effect of organic anions and vincristine.
      T S Chen, B A Wenczak and K C Huang
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 645-649;

  5. Hubbard, J W

    1. A study of the kinetics of chlorpromazine sulfoxide by a specific radioimmunoassay after a single oral dose of chlorpromazine in healthy volunteers.
      P K Yeung, J W Hubbard, J K Cooper and K K Midha
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 833-838;

J

  1. James, M K

    1. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
      L X Cubeddu, I S Hoffmann, M K James and D M Niedzwiecki
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 680-685;

  2. Johnson, C E

    1. Dopamine antagonist effect of verapamil on isolated perfused rabbit ear artery.
      C E Johnson, O S Steinsland and A Scriabine
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 802-805;

K

  1. Katz, J L

    1. Effects of drugs on stimulus control of behavior. II. Degree of stimulus control as a determinant of effect.
      J L Katz
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 756-763;

  2. Koe, B K

    1. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
      B K Koe, A Weissman, W M Welch and R G Browne
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 686-700;

  3. Krieger, A J

    1. Medullary gamma-aminobutyric acid (GABA) receptors and the regulation of blood pressure in the rat.
      R N Willette, A J Krieger, P P Barcas and H N Sapru
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 893-899;

L

  1. Lee, N M

    1. Functional opiate receptor in mouse vas deferens: evidence for a complex interaction.
      P Sánchez-Blázquez, J Garzón and N M Lee
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 706-711;

  2. Lindberg, B

    1. Styrene oxide metabolism in rhesus monkey liver: enzyme activities in subcellular fractions and in isolated hepatocytes.
      G M Pacifici, B Lindberg, H Glaumann and A Rane
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 869-875;

  3. Lindmar, R

    1. Mobilization of cellular choline by stimulation of muscarine receptors in isolated chicken heart and rat cortex in vivo.
      R Corradetti, R Lindmar and K Löffelholz
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 826-832;

  4. Lipchuck, L M

    1. Antihypertensive activity of dl-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl prostaglandin E2 methyl ester (CL 115,347), a new orally and transdermally long-acting antihypertensive agent.
      P S Chan, P Cervoni, M A Ronsberg, R C Accomando, G J Quirk, P A Scully and L M Lipchuck
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 726-732;

  5. Löffelholz, K

    1. Mobilization of cellular choline by stimulation of muscarine receptors in isolated chicken heart and rat cortex in vivo.
      R Corradetti, R Lindmar and K Löffelholz
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 826-832;

  6. Löscher, W

    1. High anticonvulsant potency of gamma-aminobutyric acid (GABA)mimetic drugs in gerbils with genetically determined epilepsy.
      W Löscher, H H Frey, R Reiche and D Schultz
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 839-844;
    2. Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment.
      W Löscher and H Nau
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 845-854;

M

  1. Malik, K U

    1. Enhancement by locally generated angiotensin II of release of the adrenergic transmitter in the isolated rat kidney.
      T Böke and K U Malik
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 900-907;

  2. Marks, M J

    1. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors.
      M J Marks, J B Burch and A C Collins
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 817-825;

  3. Martin, W R

    1. Physical dependence on diazepam and lorazepam in the dog.
      L F McNicholas, W R Martin and S Cherian
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 783-789;

  4. Mayersohn, M

    1. Phencyclidine blood protein binding: influence of protein, pH and species.
      S M Owens, M Mayersohn and J R Woodworth
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 656-660;

  5. McCown, T J

    1. Differential sensitivity of ethanol withdrawal signs in the rat to gamma-aminobutyric acid (GABA)mimetics: blockade of audiogenic seizures but not forelimb tremors.
      G D Frye, T J McCown and G R Breese
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 720-725;

  6. McNicholas, L F

    1. Physical dependence on diazepam and lorazepam in the dog.
      L F McNicholas, W R Martin and S Cherian
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 783-789;

  7. Meyer, E R

    1. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
      T J Cicero, D P Owens, P F Schmoeker and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 770-775;

  8. Midha, K K

    1. A study of the kinetics of chlorpromazine sulfoxide by a specific radioimmunoassay after a single oral dose of chlorpromazine in healthy volunteers.
      P K Yeung, J W Hubbard, J K Cooper and K K Midha
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 833-838;

  9. Miller, R J

    1. Stimulation of prostaglandin production in rabbit ileal mucosa by bradykinin.
      S A Hojvat, M W Musch and R J Miller
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 749-755;

  10. Mimnaugh, E G

    1. Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers.
      E G Mimnaugh, T E Gram and M A Trush
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 806-816;

  11. Moerschbaecher, J M

    1. Differential effects of prototype opioid agonists on the acquisition of conditional discriminations in monkeys.
      J M Moerschbaecher and D M Thompson
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 738-748;

  12. Musch, M W

    1. Stimulation of prostaglandin production in rabbit ileal mucosa by bradykinin.
      S A Hojvat, M W Musch and R J Miller
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 749-755;

N

  1. Nakamura, J

    1. Effects of glial uptake and desensitization on the activity of gamma-aminobutyric acid (GABA) and its analogs at the cat dorsal root ganglion.
      J P Gallagher, J Nakamura and P Shinnick-Gallagher
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 876-884;

  2. Nau, H

    1. Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment.
      W Löscher and H Nau
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 845-854;

  3. Niedzwiecki, D M

    1. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
      L X Cubeddu, I S Hoffmann, M K James and D M Niedzwiecki
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 680-685;

O

  1. Owens, D P

    1. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
      T J Cicero, D P Owens, P F Schmoeker and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 770-775;

  2. Owens, S M

    1. Phencyclidine blood protein binding: influence of protein, pH and species.
      S M Owens, M Mayersohn and J R Woodworth
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 656-660;

P

  1. Pacifici, G M

    1. Styrene oxide metabolism in rhesus monkey liver: enzyme activities in subcellular fractions and in isolated hepatocytes.
      G M Pacifici, B Lindberg, H Glaumann and A Rane
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 869-875;

  2. Peach, M J

    1. Endothelium-dependent relaxation of rabbit aorta. I. Relaxation stimulated by arachidonic acid.
      H A Singer and M J Peach
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 790-795;
    2. Endothelium-dependent relaxation of rabbit aorta. II. Inhibition of relaxation stimulated by methacholine and A23187 with antagonists of arachidonic acid metabolism.
      H A Singer and M J Peach
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 796-801;

Q

  1. Quirk, G J

    1. Antihypertensive activity of dl-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl prostaglandin E2 methyl ester (CL 115,347), a new orally and transdermally long-acting antihypertensive agent.
      P S Chan, P Cervoni, M A Ronsberg, R C Accomando, G J Quirk, P A Scully and L M Lipchuck
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 726-732;

R

  1. Rane, A

    1. Styrene oxide metabolism in rhesus monkey liver: enzyme activities in subcellular fractions and in isolated hepatocytes.
      G M Pacifici, B Lindberg, H Glaumann and A Rane
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 869-875;

  2. Ransom, R W

    1. Xylamine, an irreversible inhibitor of norepinephrine uptake, is transported by this same uptake mechanism in cultured rat superior cervical ganglia.
      J B Fischer, L A Waggaman, R W Ransom and A K Cho
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 650-655;

  3. Rech, R H

    1. Negative chronotropic and positive inotropic actions of phencyclidine on isolated atrial muscle in guinea pigs and rats.
      K Temma, T Akera, T M Brody and R H Rech
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 885-892;

  4. Reiche, R

    1. High anticonvulsant potency of gamma-aminobutyric acid (GABA)mimetic drugs in gerbils with genetically determined epilepsy.
      W Löscher, H H Frey, R Reiche and D Schultz
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 839-844;

  5. Reinhard, J F

    1. Noradrenergic modulation of serotonin synthesis and metabolism. II. Stimulation by 3-isobutyl-1-methylxanthine.
      J F Reinhard, M P Galloway and R H Roth
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 764-769;

  6. Rimele, T J

    1. Alpha-1 adrenoceptors and calcium in isolated canine coronary arteries.
      T J Rimele, T W Rooke, L L Aarhus and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 668-672;

  7. Robie, N W

    1. Evaluation of presynaptic histamine receptors in the canine renal vascular bed.
      N W Robie and L A Barker
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 712-719;

  8. Ronsberg, M A

    1. Antihypertensive activity of dl-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl prostaglandin E2 methyl ester (CL 115,347), a new orally and transdermally long-acting antihypertensive agent.
      P S Chan, P Cervoni, M A Ronsberg, R C Accomando, G J Quirk, P A Scully and L M Lipchuck
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 726-732;

  9. Rooke, T W

    1. Alpha-1 adrenoceptors and calcium in isolated canine coronary arteries.
      T J Rimele, T W Rooke, L L Aarhus and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 668-672;

  10. Roth, R A

    1. Total body clearance of circulating benzo(a)pyrene in conscious rats: effect of pretreatment with 3-methylcholanthrene and the role of liver and lung.
      D A Wiersma and R A Roth
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 661-667;

  11. Roth, R H

    1. Noradrenergic modulation of serotonin synthesis and metabolism. II. Stimulation by 3-isobutyl-1-methylxanthine.
      J F Reinhard, M P Galloway and R H Roth
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 764-769;

S

  1. Sánchez-Blázquez, P

    1. Functional opiate receptor in mouse vas deferens: evidence for a complex interaction.
      P Sánchez-Blázquez, J Garzón and N M Lee
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 706-711;

  2. Sapru, H N

    1. Medullary gamma-aminobutyric acid (GABA) receptors and the regulation of blood pressure in the rat.
      R N Willette, A J Krieger, P P Barcas and H N Sapru
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 893-899;

  3. Schechter, M D

    1. Pre- and postnatal effects of caffeine on brain biogenic amines, cyclic nucleotides and behavior in developing rats.
      J T Concannon, J M Braughler and M D Schechter
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 673-679;

  4. Schmoeker, P F

    1. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
      T J Cicero, D P Owens, P F Schmoeker and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 770-775;

  5. Schultz, D

    1. High anticonvulsant potency of gamma-aminobutyric acid (GABA)mimetic drugs in gerbils with genetically determined epilepsy.
      W Löscher, H H Frey, R Reiche and D Schultz
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 839-844;

  6. Scriabine, A

    1. Dopamine antagonist effect of verapamil on isolated perfused rabbit ear artery.
      C E Johnson, O S Steinsland and A Scriabine
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 802-805;

  7. Scully, P A

    1. Antihypertensive activity of dl-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl prostaglandin E2 methyl ester (CL 115,347), a new orally and transdermally long-acting antihypertensive agent.
      P S Chan, P Cervoni, M A Ronsberg, R C Accomando, G J Quirk, P A Scully and L M Lipchuck
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 726-732;

  8. Shinnick-Gallagher, P

    1. Effects of glial uptake and desensitization on the activity of gamma-aminobutyric acid (GABA) and its analogs at the cat dorsal root ganglion.
      J P Gallagher, J Nakamura and P Shinnick-Gallagher
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 876-884;

  9. Singer, H A

    1. Endothelium-dependent relaxation of rabbit aorta. I. Relaxation stimulated by arachidonic acid.
      H A Singer and M J Peach
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 790-795;
    2. Endothelium-dependent relaxation of rabbit aorta. II. Inhibition of relaxation stimulated by methacholine and A23187 with antagonists of arachidonic acid metabolism.
      H A Singer and M J Peach
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 796-801;

  10. Steinsland, O S

    1. Dopamine antagonist effect of verapamil on isolated perfused rabbit ear artery.
      C E Johnson, O S Steinsland and A Scriabine
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 802-805;

T

  1. Temma, K

    1. Negative chronotropic and positive inotropic actions of phencyclidine on isolated atrial muscle in guinea pigs and rats.
      K Temma, T Akera, T M Brody and R H Rech
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 885-892;

  2. Thompson, D M

    1. Differential effects of prototype opioid agonists on the acquisition of conditional discriminations in monkeys.
      J M Moerschbaecher and D M Thompson
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 738-748;

  3. Timmermans, P B

    1. Differential role of M-1 and M-2 receptors in sympathetic ganglia of the pithed normotensive rat in alpha adrenoceptor-mediated vasoconstriction.
      B Wilffert, D Davidesko, P B Timmermans and P A van Zwieten
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 855-860;

  4. Toda, N

    1. Alpha adrenergic receptor subtypes in human, monkey and dog cerebral arteries.
      N Toda
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 861-868;

  5. Trush, M A

    1. Stimulation of mouse heart and liver microsomal lipid peroxidation by anthracycline anticancer drugs: characterization and effects of reactive oxygen scavengers.
      E G Mimnaugh, T E Gram and M A Trush
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 806-816;

  6. Tune, B M

    1. Reactivity and binding of beta-lactam antibiotics in rabbit renal cortex.
      M C Browning and B M Tune
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 640-644;

V

  1. Vanhoutte, P M

    1. Alpha-1 adrenoceptors and calcium in isolated canine coronary arteries.
      T J Rimele, T W Rooke, L L Aarhus and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 668-672;

  2. van Zwieten, P A

    1. Differential role of M-1 and M-2 receptors in sympathetic ganglia of the pithed normotensive rat in alpha adrenoceptor-mediated vasoconstriction.
      B Wilffert, D Davidesko, P B Timmermans and P A van Zwieten
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 855-860;

W

  1. Waggaman, L A

    1. Xylamine, an irreversible inhibitor of norepinephrine uptake, is transported by this same uptake mechanism in cultured rat superior cervical ganglia.
      J B Fischer, L A Waggaman, R W Ransom and A K Cho
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 650-655;

  2. Weissman, A

    1. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
      B K Koe, A Weissman, W M Welch and R G Browne
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 686-700;

  3. Welch, W M

    1. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
      B K Koe, A Weissman, W M Welch and R G Browne
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 686-700;

  4. Wenczak, B A

    1. Transport of methotrexate in cortical slices of monkey kidney: effect of organic anions and vincristine.
      T S Chen, B A Wenczak and K C Huang
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 645-649;

  5. Wiersma, D A

    1. Total body clearance of circulating benzo(a)pyrene in conscious rats: effect of pretreatment with 3-methylcholanthrene and the role of liver and lung.
      D A Wiersma and R A Roth
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 661-667;

  6. Wilffert, B

    1. Differential role of M-1 and M-2 receptors in sympathetic ganglia of the pithed normotensive rat in alpha adrenoceptor-mediated vasoconstriction.
      B Wilffert, D Davidesko, P B Timmermans and P A van Zwieten
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 855-860;

  7. Willette, R N

    1. Medullary gamma-aminobutyric acid (GABA) receptors and the regulation of blood pressure in the rat.
      R N Willette, A J Krieger, P P Barcas and H N Sapru
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 893-899;

  8. Woodworth, J R

    1. Phencyclidine blood protein binding: influence of protein, pH and species.
      S M Owens, M Mayersohn and J R Woodworth
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 656-660;

Y

  1. Yeung, P K

    1. A study of the kinetics of chlorpromazine sulfoxide by a specific radioimmunoassay after a single oral dose of chlorpromazine in healthy volunteers.
      P K Yeung, J W Hubbard, J K Cooper and K K Midha
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 833-838;

  2. Yocca, F D

    1. Effect of chronic lithium treatment on rat pineal rhythms: N-acetyltransferase, N-acetylserotonin and melatonin.
      F D Yocca, V de Paul Lynch and E Friedman
      Journal of Pharmacology and Experimental Therapeutics September 1983, 226 (3) 733-737;
Back to top

In this issue

Advertisement